Navigation Links
Sox 18 Slows Cancers

A new gene which has the ability to slow down cancer growth has been identified by medical researchers. Cancer kills millions of people each year, and luckily tthe discovery of the new gene,called Sox 18, will help targeting the cancer of the colon, prostate,pancreas,brain and bowel.

Sox regulates blood vessel development and could be manipulated to stunt the cancer by starving the tumour cells.//

This discoverywas made by Peter Koopman and George Muscat at the University of Queensland's Institute for Molecular Bioscience.

"Tumours cannot grow above a certain size unless they attract growth of blood vessels, so by being able to control blood vessel development we may be ble to slow or stop the cancer, and the next step will be to establish which genes interact with Sox 18 to control blood vessel development and also what processes are required within cells to produce the final effects," Dr Koopman said. This gene could also be manipulated to do the reverse: to speed up blood vessel development to help heal wounds faster, and to treat circulation problems which could otherwise lead to limb amputation in diabetics. As a matter of fact this research has brought light to the scope of life of many cancer patients.
'"/>




Page: 1

Related medicine news :

1. Early Diagnosis and Treatment Slows Progression of Dementia
2. MRIs Show Drug Treatment Slows Brain Deterioration on Road to Alzheimers Disease
3. AIDS Pandemic Slows Population Growth In South Africa
4. Drug Treatment Slows Macular Vision Loss in Diabetics
5. Learning Slows Physical Progression of Alzheimers Disease: Study
6. Wearing No-line Bifocals Slows Myopia Progression in Some Children
7. Higher Physical Activity Level Slows Lung Function Decline in Smokers
8. Cancers of Colon & Rectum linked to Cigarette Smoking
9. Cancers & Reconstruction
10. Radiation Not Needed for Childhood Cancers
11. New Treatment for Some Cancers

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Sox Slows Cancers

(Date:12/4/2009)... North American Seminars Inc....host continuing medical education courses at their...acility to showcase its operation and capabilities...overall costs to educate their physical therapy an...45 facilities hosted over 250 live training events...
(Date:12/4/2009)... The renowned Center for mind...ow offering the only natural immuno-boosting herba...les of Ayurveda. , San Di...s age of unprecedented illness due to factors such...nza strain millions of people around the world are...
(Date:12/3/2009)... With a membership increase o...his achievement not only as a milestone in its his...;s relevance. Most associations are experiencing a...my.,“At a time when trade organizations acr...he FMA is experiencing unprecedented growth, signa...
(Date:12/3/2009)... , MINNEAPOLIS, Dec. 3 Child...named a recipient of the 2009 Leapfrog Top Hospita... for delivering care that is among the best in the... efficiency. ,, The Leapfrog survey is the only...ssues including mortality rates for common procedu...
(Date:12/3/2009)... , BEVERLY HILLS, Calif., Dec. 3 /PRNewswire...s year,s Divine Design Gala and Premier Shopping E...be priced at 50-70% off regular prices. The event...h Monday, December 7, 2009, located at 9900 Wilshi...ls, California. Please visit www.divinedesign.or...
Breaking Medicine News(10 mins):Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 2Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 3Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 4Health News:The Chopra Center for Wellbeing Launches Vedamune: An Ayurvedic Supplement to Support The Immune System 2Health News:Florida Medical Association Marks Record Membership Growth 2Health News:Children's Hospitals and Clinics of Minnesota Receives National Recognition for Quality and Efficiency 2Health News:Christian Audigier Represented at Divine Design for Project Angel Food 2
... begun to solve some of the mysteries of the commo...ic codes for all the known strains of the human rh...d School of Medicine in Baltimore and colleagues a... viruses are related, with their commonalities and...
... on moveable platform kept better balance in a sli...hDay News) -- Repeatedly exposing people to situat...em to maintain their balance on slippery floors an...gies that can be used in a variety of situations. ...
...Feb. 20 During the annual Promesa y Esperan...dio, the leading Spanish-language radio group, His...elp save kids battling cancer at St. Jude Childre...an $6 million in cash and pledges to help St. Jude...
..., Feb. 20 China Healthcare Acquisition Corp. (the... announced today that its Board of Directors has s...g the stockholders entitled to receive liquidatin...roceeds of the IPO were deposited. The Company ha...
...ecutive Acknowledges ,Tireless Determination, to F..., Businesses and Community Leaders to Collaborate ...Y, Calif., Feb. 20 Following six long weeks of ne...olicymakers, business, health care and other secto...
...ELEASE UNTIL 4:00 P.M., ET, FRIDAY, FEBRUARY 20, 2...9, janderson@aan.com ,Jay Mac Bride, (651) 695-27...isk for Multiple Sclerosis , SEATTLE People who ... at the American Academy of Neurology,s 61st Annua...
Other Medicine News:Health News:Researchers crack the code of the common cold 2Health News:Researchers crack the code of the common cold 3Health News:Researchers crack the code of the common cold 4Health News:Adapting Gait May Help Elderly Avoid Falls 2Health News:Hispanics Across the Country Pledge More Than $6 Million During Univision Radio Event to Help St. Jude Fight Childhood Cancer 2Health News:Hispanics Across the Country Pledge More Than $6 Million During Univision Radio Event to Help St. Jude Fight Childhood Cancer 3Health News:China Healthcare Acquisition Announces Record Date for Trust Fund Distribution 2Health News:Barry Arbuckle, PhD, MemorialCare Medical Centers CEO and Immediate Past Chair, California Hospital Association, Speaks Out on California Budget Passage 2
(Date:12/3/2009)..., Dec. 3 A genetic varia...ing a potentially life-threatening blood disorder ...chemicals is one of several medical discoveries sc...stics (NYSE: DGX ) will present during the 51st ...g and Exposition, December 5-8, 2009, in New Orlea...
(Date:12/3/2009)...c. 3 BioMed Realty Trust...entered into a new lease with Regeneron Pharmaceut...,000 square feet of additional, newly-constructed ...tview campus in Tarrytown, New York. The new lease...l space was completed approximately two months aft...
(Date:12/3/2009)...OERSHOLM, Denmark and SAN DIEGO, California, Decem...fully Inhibits miR-122, a microRNA Important for,H...y Reducing Hepatitis C,Virus in the Bloodstream in...is C Virus , - SPC3649 Demonstrates Effic...rious Adverse Events in the Treated Animals - Sign...
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Astellas and The National Science Teachers Association Announce 2009 Class of Local Science Educators 57780 1Astellas and The National Science Teachers Association Announce 2009 Class of Local Science Educators 57780 2Astellas and The National Science Teachers Association Announce 2009 Class of Local Science Educators 57780 3Thomson Reuters Launches Thomson Pharma Partnering Forecast 57778 1Thomson Reuters Launches Thomson Pharma Partnering Forecast 57778 2Nuvilex Inc Announced that Reme Flu 28TM 29 will Incorporate Proprietary Syn X9 28TM 29 Delivery Technology into its Product Formulation 14179 1Nuvilex Inc Announced that Reme Flu 28TM 29 will Incorporate Proprietary Syn X9 28TM 29 Delivery Technology into its Product Formulation 14179 2Nuvilex Inc Announced that Reme Flu 28TM 29 will Incorporate Proprietary Syn X9 28TM 29 Delivery Technology into its Product Formulation 14179 3
...armaceuticals, Inc.,(OTC Bulletin Board: ACCP) ann... using the company,s proprietary Cobalamin(TM) tec... an animal model of diabetes, through,its oral ins... Cobalamin,which is based upon the body,s natural ...tract, were tested in an animal model of diabetes....
...m 11 PROCRIT(R) (Epoetin alfa),studies will be pre... 49th,Annual Meeting and Exposition December 8 - 1...ghts including:, -- the potential impact on the n...ythropoiesis-stimulating agents (ESAs) for the tre...-- the use of PROCRIT in extended dosing regimens;...
Other Medicine Technology:Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin 2Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin 3PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 2PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 3PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 4PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 5PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 6PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 7PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 8PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 9
Optima III Noninsulated Allis Tooth Grasper, without ratchet
Optima III Noninsulated Duck-Bill Grasper, with ratchet
Uninsulated locking handle
Snap-In Snap-Out®-II Single Ring Handle, ratcheted, noninsulated handle, insulated shaft
Medicine Products: